Bergen, Norway, 30 May 2024: Today, at 13:00 CEST Lifecare CEO Joacim Holter will participate at Redeye Growth Day 2024 and present the latest development of the company.
******
Lifecare ASA is a clinical stage medical sensor company developing technology for sensing and monitoring of various body analytes. Lifecare’s main focus is to bring the next generation of Continuous Glucose Monitoring (“CGM”) systems to market.
Lifecare enables osmotic pressure as sensing principle, combined with the ability to manipulate Nano-granular Tunnelling Resistive sensors (“NTR”) on the sensor body for read-out of pressure variations. Lifecare´s sensor technology is referred to as “Sencell” and is suitable for identifying and monitoring the occurrence of a wide range of analytes and molecules in the human body and in pets.
The presentation is live broadcasted and can be followed at https://www.redeye.se/events/981085/redeye-growth-day-2024 where the replay and the presentations will be available afterwards.